Realising milestones with gene therapy for SMA
European Pharmaceutical Review
MAY 11, 2023
Three SMN-enhancing treatments for the condition are approved by the US Food and Drug Administration (FDA) 2 , however there is no cure for SMA at present. References Pharma spending per capita; 3.8% This is often called an ‘SMN-based’ or ‘SMN-enhancing’ approach.
Let's personalize your content